ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.4163dup (p.Ser1389fs) (rs80357788)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Breast Cancer Information Core (BIC) (BRCA1) RCV000112272 SCV000144999 pathogenic Breast-ovarian cancer, familial 1 2002-06-20 no assertion criteria provided clinical testing
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000112272 SCV000300083 pathogenic Breast-ovarian cancer, familial 1 2016-09-08 reviewed by expert panel curation Variant allele predicted to encode a truncated non-functional protein.
Integrated Genetics/Laboratory Corporation of America RCV000586207 SCV000699095 pathogenic Hereditary breast and ovarian cancer syndrome 2016-04-22 criteria provided, single submitter clinical testing Variant summary: The c.4163dupA variant results in a premature termination codon, predicted to cause a truncated or absent BRCA1 protein, which is a commonly known mechanism for disease. Truncations downstream of this position, such as c.4165_4166delAG, c.4167delT, c.4167_4168delTG, c.4165_4166dupAG, have been classified as "Pathogenic". This variant has been reported in at least two BrC patients and is not found in 94812 control chromosomes. In addition, one reputable database classified this variant as pathogenic. Taken together, this variant was classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.